内脏肥胖及相关指标与2型糖尿病关系的研究进展
Research Progress on the Relationship between Visceral Obesity and Related Indices and Type 2 Diabetes Mellitus
DOI: 10.12677/jcpm.2025.42161, PDF,   
作者: 谭娅娟, 沙永红:吉首大学医学院,湖南 吉首;甘胜莲*:中南大学湘雅医学院附属常德医院内分泌科,湖南 常德
关键词: 内脏肥胖2型糖尿病内脏肥胖相关指标Visceral Obesity Type 2 Diabetes Mellitus Visceral Obesity-Related Indices
摘要: 肥胖或体重过度增加被确认为2型糖尿病(T2DM)发生和进展中最重要且显著的危险因素,特别是内脏肥胖。肥胖问题已达到大流行的程度,使得对肥胖的治疗在预防和管理T2DM中显得尤为重要。关于不同内脏肥胖指标对T2DM和内脏肥胖风险的预测效果仍存在争议。本文旨在综述体重指数(BMI)、腰围(WC)、腰臀比(WHR)、腰高比(WHtR)、内脏脂肪指数(VAI)、中国内脏脂肪指数(CVAI)、内脏脂肪代谢评分(METS-VF)、新的内脏肥胖指数(NVAI)内脏肥胖相关指标与T2DM和内脏肥胖风险之间关系的研究进展,以更好地应对日益流行的T2DM及肥胖。
Abstract: Obesity or excessive weight gain has been identified as one of the most significant risk factors for the development and progression of type 2 diabetes mellitus (T2DM), especially visceral obesity. The obesity epidemic has reached pandemic proportions, making obesity treatment crucial in the prevention and management of T2DM. However, there is still controversy regarding the predictive effectiveness of different visceral obesity indices on the risks of T2DM and visceral obesity. This article aims to review the research progress on the relationship between visceral obesity-related indices, including Body Mass Index (BMI), Waist Circumference (WC), Waist-to-Hip Ratio (WHR), Waist-to-Height Ratio (WHtR), Visceral Adiposity Index (VAI), Chinese Visceral Adiposity Index (CVAI), new Metabolic Score for Visceral fat (METS-VF), and New Visceral Adiposity Index (NVAI), and the risks of T2DM and visceral obesity. This review aims to better address the increasingly prevalent issues of T2DM and obesity.
文章引用:谭娅娟, 甘胜莲, 沙永红. 内脏肥胖及相关指标与2型糖尿病关系的研究进展[J]. 临床个性化医学, 2025, 4(2): 175-185. https://doi.org/10.12677/jcpm.2025.42161

参考文献

[1] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) (下) [J]. 中国实用内科杂志, 2021, 41(9): 757-784.
[2] Zhang, L.F., Wang, Z.W., Wang, X., Chen, Z., Shao, L., Tian, Y., et al. (2020) Prevalence of Overweight and Obesity in China: Results from a Cross-Sectional Study of 441 Thousand Adults, 2012-2015. Obesity Research & Clinical Practice, 14, 119-126. [Google Scholar] [CrossRef] [PubMed]
[3] 中华医学会内分泌学分会. 中国2型糖尿病合并肥胖综合管理专家共识[J]. 药品评价, 2016, 13(17): 5-10+2.
[4] Dhokte, S. and Czaja, K. (2024) Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes. Nutrients, 16, Article 1015. [Google Scholar] [CrossRef] [PubMed]
[5] Shuster, A., Patlas, M., Pinthus, J.H. and Mourtzakis, M. (2012) The Clinical Importance of Visceral Adiposity: A Critical Review of Methods for Visceral Adipose Tissue Analysis. The British Journal of Radiology, 85, 1-10. [Google Scholar] [CrossRef] [PubMed]
[6] Gadekar, T., Dudeja, P., Basu, I., Vashisht, S. and Mukherji, S. (2020) Correlation of Visceral Body Fat with Waist-Hip Ratio, Waist Circumference and Body Mass Index in Healthy Adults: A Cross Sectional Study. Medical Journal Armed Forces India, 76, 41-46. [Google Scholar] [CrossRef] [PubMed]
[7] Xia, M.-F., Chen, Y., Lin, H.-D., Ma, H., Li, X.-M., Aleteng, Q., et al. (2016) A Indicator of Visceral Adipose Dysfunction to Evaluate Metabolic Health in Adult Chinese. Scientific Reports, 6, Article No. 38214. [Google Scholar] [CrossRef] [PubMed]
[8] Bello-Chavolla, O.Y., Antonio-Villa, N.E., Vargas-Vázquez, A., Viveros-Ruiz, T.L., Almeda-Valdes, P., Gomez-Velasco, D., et al. (2020) Metabolic Score for Visceral Fat (METS-VF), a Novel Estimator of Intra-Abdominal Fat Content and Cardio-Metabolic Health. Clinical Nutrition, 39, 1613-1621. [Google Scholar] [CrossRef] [PubMed]
[9] Oh, S.-K., Cho, A.-R., Kwon, Y.-J., Lee, H.-S. and Lee, J.-W. (2018) Derivation and Validation of a New Visceral Adiposity Index for Predicting Visceral Obesity and Cardiometabolic Risk in a Korean Population. PLOS ONE, 13, e0203787. [Google Scholar] [CrossRef] [PubMed]
[10] Amato, M.C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., et al. (2010) Visceral Adiposity Index. Diabetes Care, 33, 920-922. [Google Scholar] [CrossRef] [PubMed]
[11] An, S.-M., Cho, S.-H. and Yoon, J.C. (2023) Adipose Tissue and Metabolic Health. Diabetes & Metabolism Journal, 47, 595-611. [Google Scholar] [CrossRef] [PubMed]
[12] Santillana, N., Astudillo-Guerrero, C., D’Espessailles, A. and Cruz, G. (2023) White Adipose Tissue Dysfunction: Pathophysiology and Emergent Measurements. Nutrients, 15, Article 1722. [Google Scholar] [CrossRef] [PubMed]
[13] Daryabor, G., Kabelitz, D. and Kalantar, K. (2019) An Update on Immune Dysregulation in Obesity‐Related Insulin Resistance. Scandinavian Journal of Immunology, 89, e12747. [Google Scholar] [CrossRef] [PubMed]
[14] Szukiewicz, D. (2023) Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity. International Journal of Molecular Sciences, 24, Article 9818. [Google Scholar] [CrossRef] [PubMed]
[15] Kolb, H. (2022) Obese Visceral Fat Tissue Inflammation: From Protective to Detrimental? BMC Medicine, 20, Article No. 494. [Google Scholar] [CrossRef] [PubMed]
[16] McLaughlin, T., Ackerman, S.E., Shen, L. and Engleman, E. (2017) Role of Innate and Adaptive Immunity in Obesity-Associated Metabolic Disease. Journal of Clinical Investigation, 127, 5-13. [Google Scholar] [CrossRef] [PubMed]
[17] Corbin, J.A., Bhaskar, V., Goldfine, I.D., Issafras, H., Bedinger, D.H., Lau, A., et al. (2013) Inhibition of Insulin Receptor Function by a Human, Allosteric Monoclonal Antibody. Mabs, 6, 262-272. [Google Scholar] [CrossRef] [PubMed]
[18] Willard, D.L., Stevenson, M. and Steenkamp, D. (2016) Type B Insulin Resistance Syndrome. Current Opinion in Endocrinology, Diabetes & Obesity, 23, 318-323. [Google Scholar] [CrossRef] [PubMed]
[19] Pei, J.L., Wang, B.C. and Wang, D.Y. (2022) Current Studies on Molecular Mechanisms of Insulin Resistance. Journal of Diabetes Research, 2022, Article 1863429. [Google Scholar] [CrossRef] [PubMed]
[20] Boucher, J., Kleinridders, A. and Kahn, C.R. (2014) Insulin Receptor Signaling in Normal and Insulin-Resistant States. Cold Spring Harbor Perspectives in Biology, 6, a009191-a009191. [Google Scholar] [CrossRef] [PubMed]
[21] Singh, A., Kukreti, R., Saso, L. and Kukreti, S. (2022) Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes. Molecules, 27, Article 950. [Google Scholar] [CrossRef] [PubMed]
[22] Zhao, X.F., An, X.D., Yang, C.Q., Sun, W.J., Ji, H.Y. and Lian, F.M. (2023) The Crucial Role and Mechanism of Insulin Resistance in Metabolic Disease. Frontiers in Endocrinology, 14, Article 1149239. [Google Scholar] [CrossRef] [PubMed]
[23] Petersen, M.C. and Shulman, G.I. (2018) Mechanisms of Insulin Action and Insulin Resistance. Physiological Reviews, 98, 2133-2223. [Google Scholar] [CrossRef] [PubMed]
[24] Usui, C., Asaka, M., Kawano, H., Aoyama, T., Ishijima, T., Sakamoto, S., et al. (2010) Visceral Fat Is a Strong Predictor of Insulin Resistance Regardless of Cardiorespiratory Fitness in Non-Diabetic People. Journal of Nutritional Science and Vitaminology, 56, 109-116. [Google Scholar] [CrossRef] [PubMed]
[25] Narayan, K.M.V. and Kanaya, A.M. (2020) Why Are South Asians Prone to Type 2 Diabetes? A Hypothesis Based on Underexplored Pathways. Diabetologia, 63, 1103-1109. [Google Scholar] [CrossRef] [PubMed]
[26] Sears, B. and Perry, M. (2015) The Role of Fatty Acids in Insulin Resistance. Lipids in Health and Disease, 14, Article No. 121. [Google Scholar] [CrossRef] [PubMed]
[27] Chakrabarti, P., Kim, J.Y., Singh, M., Shin, Y., Kim, J., Kumbrink, J., et al. (2013) Insulin Inhibits Lipolysis in Adipocytes via the Evolutionarily Conserved mTORC1-Egr1-ATGL-Mediated Pathway. Molecular and Cellular Biology, 33, 3659-3666. [Google Scholar] [CrossRef] [PubMed]
[28] Hegarty, B.D., Furler, S.M., Ye, J., Cooney, G.J. and Kraegen, E.W. (2003) The Role of Intramuscular Lipid in Insulin Resistance. Acta Physiologica Scandinavica, 178, 373-383. [Google Scholar] [CrossRef] [PubMed]
[29] 《肥胖症诊疗指南 (2024年版)》发布[J]. 祝您健康, 2024(12): 3.
[30] Lu, J.R., Liu, X.S., Jiang, S., Kan, S.Y., An, Y., Zheng, C.X., et al. (2022) Body Mass Index and Risk of Diabetic Nephropathy: A Mendelian Randomization Study. The Journal of Clinical Endocrinology & Metabolism, 107, 1599-1608. [Google Scholar] [CrossRef] [PubMed]
[31] Polemiti, E., Baudry, J., Kuxhaus, O., Jäger, S., Bergmann, M.M., Weikert, C., et al. (2021) BMI and BMI Change Following Incident Type 2 Diabetes and Risk of Microvascular and Macrovascular Complications: The EPIC-Potsdam Study. Diabetologia, 64, 814-825. [Google Scholar] [CrossRef] [PubMed]
[32] Chen, J.H., Li, Y.T., Niu, Z.M., He, Z.P., Xie, Y.J., Hernandez, J., et al. (2024) Investigating the Causal Association of Generalized and Abdominal Obesity with Microvascular Complications in Patients with Type 2 Diabetes: A Community‐based Prospective Study. Diabetes, Obesity and Metabolism, 26, 2796-2810. [Google Scholar] [CrossRef] [PubMed]
[33] Yang, Z.M., Shen, P., Qu, Y.L., Xu, L.S., Li, T.Z., Zhu, Z.H., et al. (2023) Baseline and Longitudinal Trajectories of Body-Mass Index and All-Cause Mortality among Patients with Type 2 Diabetes. Diabetes & Metabolism, 49, Article 101426. [Google Scholar] [CrossRef] [PubMed]
[34] Massey, R.J., Chen, Y., Panova-Noeva, M., Mattheus, M., Siddiqui, M.K., Schloot, N.C., et al. (2024) BMI Variability and Cardiovascular Outcomes within Clinical Trial and Real-World Environments in Type 2 Diabetes: An IMI2 SOPHIA Study. Cardiovascular Diabetology, 23, Article No. 256. [Google Scholar] [CrossRef] [PubMed]
[35] Boonpor, J., Parra‐Soto, S., Talebi, A., Zhou, Z., Carrasco‐Marin, F., Petermann‐Rocha, F., et al. (2023) Associations and Predictive Performance of 11 Anthropometric Measures with Incident Type 2 Diabetes: A Prospective Cohort Study from the Uk Biobank. Obesity, 31, 2648-2657. [Google Scholar] [CrossRef] [PubMed]
[36] Li, S., Wang, Y., Ying, Y., et al. (2023) Independent and Joint Associations of BMI and Waist Circumference with the Onset of Type 2 Diabetes Mellitus in Chinese Adults: Prospective Data Linkage Study. JMIR Public Health and Surveillance, 9, e39459.
[37] Strings, S., Wells, C., Bell, C. and Tomiyama, A.J. (2023) The Association of Body Mass Index and Odds of Type 2 Diabetes Mellitus Varies by Race/ethnicity. Public Health, 215, 27-30. [Google Scholar] [CrossRef] [PubMed]
[38] Kong, M., Xu, M.M., Zhou, Y., Geng, N., Lin, N., Song, W.Y., et al. (2022) Assessing Visceral Obesity and Abdominal Adipose Tissue Distribution in Healthy Populations Based on Computed Tomography: A Large Multicenter Cross-Sectional Study. Frontiers in Nutrition, 9, Article 871697. [Google Scholar] [CrossRef] [PubMed]
[39] Akeroyd, J.M., Suarez, E.A., Bartali, B., Chiu, G.R., Yang, M., Schwartz, A.V., et al. (2014) Differences in Skeletal and Non-Skeletal Factors in a Diverse Sample of Men with and without Type 2 Diabetes Mellitus. Journal of Diabetes and its Complications, 28, 679-683. [Google Scholar] [CrossRef] [PubMed]
[40] Zhao, Q., Chen, X., Wu, J., Gong, L., Hu, J., Yang, S., et al. (2020) Optimal Cut-Offs of Body Mass Index and Waist Circumference to Identify Obesity in Chinese Type 2 Diabetic Patients. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 1899-1909. [Google Scholar] [CrossRef] [PubMed]
[41] Khanna, D., Peltzer, C., Kahar, P. and Parmar, M.S. (2022) Body Mass Index (BMI): A Screening Tool Analysis. Cureus, 14, e22119. [Google Scholar] [CrossRef] [PubMed]
[42] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
[43] Zhang, S.T., Li, W.Y., Jia, X.F., Zhang, J.G., Jiang, H.R., Wang, L.S., et al. (2022) Association of Obesity Profiles with Type 2 Diabetes in Chinese Adults: Findings from the China Health and Nutrition Survey. Frontiers in Nutrition, 9, Article 922824. [Google Scholar] [CrossRef] [PubMed]
[44] Chen, X., Duan, M., Hou, R., Zheng, M., Li, H., Singh, M., et al. (2021) Prevalence of Abdominal Obesity in Chinese Middle-Aged and Older Adults with a Normal Body Mass Index and Its Association with Type 2 Diabetes Mellitus: A Nationally Representative Cohort Study from 2011 to 2018. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 14, 4829-4841. [Google Scholar] [CrossRef] [PubMed]
[45] Zhao, Q.Y., Yi, X.Y. and Wang, Z.H. (2021) Meta-Analysis of the Relationship between Abdominal Obesity and Diabetic Kidney Disease in Type 2 Diabetic Patients. Obesity Facts, 14, 338-345. [Google Scholar] [CrossRef] [PubMed]
[46] Huang, Y.K.., Zhang, X.Y., Li, B., Zhu, X.Y., Li, C.X., Zhou, C.D., et al. (2023) Association of BMI and Waist Circumference with Diabetic Microvascular Complications: A Prospective Cohort Study from the UK Biobank and Mendelian Randomization Analysis. Diabetes Research and Clinical Practice, 205, Article 110975. [Google Scholar] [CrossRef] [PubMed]
[47] Zheng, C.W., Wei, X. and Cao, X.C. (2023) The Causal Effect of Obesity on Diabetic Retinopathy: A Two-Sample Mendelian Randomization Study. Frontiers in Endocrinology, 14, Article 1108731. [Google Scholar] [CrossRef] [PubMed]
[48] He, Y. and Shi, L.F. (2024) Anthropometric Indicators and Cardiovascular Diseases Risk in Pre-Diabetic and Diabetic Adults: NHANES 1999-2018 Cross-Sectional Analysis. Experimental Gerontology, 194, Article 112516. [Google Scholar] [CrossRef] [PubMed]
[49] Wan, H.W., Wang, Y.Y., Xiang, Q., Fang, S.J., Chen, Y., Chen, C., et al. (2020) Associations between Abdominal Obesity Indices and Diabetic Complications: Chinese Visceral Adiposity Index and Neck Circumference. Cardiovascular Diabetology, 19, Article No. 118. [Google Scholar] [CrossRef] [PubMed]
[50] Qiao, T.T., Luo, T., Pei, H.L., Yimingniyazi, B., Aili, D., Aimudula, A., et al. (2022) Association between Abdominal Obesity Indices and Risk of Cardiovascular Events in Chinese Populations with Type 2 Diabetes: A Prospective Cohort Study. Cardiovascular Diabetology, 21, Article No. 225. [Google Scholar] [CrossRef] [PubMed]
[51] Hulkoti, V., Acharya, S., Shukla, S., Kumar, S., Kabra, R., Dubey, A., et al. (2022) Visceral Adiposity Index in Type 2 Diabetes Mellitus (DM) and Its Correlation with Microvascular Complications. Cureus, 14, e31279. [Google Scholar] [CrossRef] [PubMed]
[52] Tuglo, L.S. (2022) Comparison of Adiposity Anthropometric Indices and Their Associations with Visceral Fat Levels Determined by Bioelectrical Impedance Analysis among Diabetic Patients. Scientific Reports, 12, Article No. 17824. [Google Scholar] [CrossRef] [PubMed]
[53] Ge, Q.W., Li, M., Xu, Z.C., Qi, Z.G., Zheng, H.Y., Cao, Y.X., et al. (2022) Comparison of Different Obesity Indices Associated with Type 2 Diabetes Mellitus among Different Sex and Age Groups in Nantong, China: A Cross-Section Study. BMC Geriatrics, 22, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[54] Zhang, X.Y., Wang, Y., Li, Y.Q., Gui, J.F., Mei, Y.J., Yang, X., et al. (2024) Optimal Obesity-and Lipid-Related Indices for Predicting Type 2 Diabetes in Middle-Aged and Elderly Chinese. Scientific Reports, 14, Article No. 10901. [Google Scholar] [CrossRef] [PubMed]
[55] Lawal, Y., Mshelia-Reng, R., Omonua, S.O., Odumodu, K., Shuaibu, R., Itanyi, U.D., et al. (2022) Comparison of Waist-Height Ratio and Other Obesity Indices in the Prediction of Diabetic Peripheral Neuropathy. Frontiers in Nutrition, 9, Article 949315. [Google Scholar] [CrossRef] [PubMed]
[56] Ke, J.-F., Wang, J.-W., Lu, J.-X., Zhang, Z.-H., Liu, Y. and Li, L.-X. (2022) Waist-to-Height Ratio Has a Stronger Association with Cardiovascular Risks than Waist Circumference, Waist-Hip Ratio and Body Mass Index in Type 2 Diabetes. Diabetes Research and Clinical Practice, 183, Article 109151. [Google Scholar] [CrossRef] [PubMed]
[57] Yi, Q., Zhu, L., Ma, J., Yu, X., Liu, L. and Shen, J. (2021) Use of Anthropometric Measures of Obesity to Predict Diabetic Retinopathy in Patients with Type 2 Diabetes in China. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 14, 4089-4095. [Google Scholar] [CrossRef] [PubMed]
[58] Liu, Y.A., Liu, K.Q., Xie, L.Q., Zuo, C.G., Wang, L.H. and Huang, W.Y. (2024) Sex-Based Differences in the Associations between Abdominal Obesity and Diabetic Retinopathy in Diabetic Patients with Normal Weight. Heliyon, 10, e36683. [Google Scholar] [CrossRef] [PubMed]
[59] Staynor, J.M.D., Smith, M.K., Donnelly, C.J., Sallam, A.E. and Ackland, T.R. (2020) DXA Reference Values and Anthropometric Screening for Visceral Obesity in Western Australian Adults. Scientific Reports, 10, Article No. 18731. [Google Scholar] [CrossRef] [PubMed]
[60] Swainson, M.G., Batterham, A.M., Tsakirides, C., Rutherford, Z.H. and Hind, K. (2017) Prediction of Whole-Body Fat Percentage and Visceral Adipose Tissue Mass from Five Anthropometric Variables. PLOS ONE, 12, e0177175. [Google Scholar] [CrossRef] [PubMed]
[61] Han, M.H., Qin, P., Li, Q.M., Qie, R.R., Liu, L.L., Zhao, Y., et al. (2020) Chinese Visceral Adiposity Index: A Reliable Indicator of Visceral Fat Function Associated with Risk of Type 2 Diabetes. Diabetes/Metabolism Research and Reviews, 37, e3370. [Google Scholar] [CrossRef] [PubMed]
[62] Tang, M., Wei, X.-H., Cao, H., Zhen, Q., Liu, F., Wang, Y.-F., et al. (2022) Association between Chinese Visceral Adiposity Index and Metabolic-Associated Fatty Liver Disease in Chinese Adults with Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 13, Article 935980. [Google Scholar] [CrossRef] [PubMed]
[63] Cheng, C., Yu, X., Shi, K., Dai, G., Pan, Q., Yuan, G., et al. (2023) Associations between Abdominal Obesity Indices with Hypertension in Type 2 Diabetes Mellitus: Chinese Visceral Adiposity Index. Journal of Endocrinological Investigation, 47, 547-555. [Google Scholar] [CrossRef] [PubMed]
[64] Liu, Q., Yu, F., Zhou, Q., Zhou, H., Lu, H., Luo, J., et al. (2024) Chinese Visceral Adipose Index Is Associated with Arterial Stiffness in Type 2 Diabetes Patients: A Cross-Sectional Study. International Journal of General Medicine, 17, 5681-5696. [Google Scholar] [CrossRef] [PubMed]
[65] Gui, J.F., Li, Y.Q., Liu, H.Y., Guo, L.-L., Li, J.L., Lei, Y.X., et al. (2023) Obesity-and Lipid-Related Indices as a Predictor of Obesity Metabolic Syndrome in a National Cohort Study. Frontiers in Public Health, 11, Article 1073824. [Google Scholar] [CrossRef] [PubMed]
[66] Yang, R., Kuang, M., Qiu, J., Yu, C., Sheng, G. and Zou, Y. (2023) Assessing the Usefulness of a Newly Proposed Metabolic Score for Visceral Fat in Predicting Future Diabetes: Results from the NAGALA Cohort Study. Frontiers in Endocrinology, 14, Article 1172323. [Google Scholar] [CrossRef] [PubMed]
[67] Zhu, Y., Zou, H., Guo, Y., Luo, P., Meng, X., Li, D., et al. (2023) Associations between Metabolic Score for Visceral Fat and the Risk of Cardiovascular Disease and All-Cause Mortality among Populations with Different Glucose Tolerance Statuses. Diabetes Research and Clinical Practice, 203, Article 110842. [Google Scholar] [CrossRef] [PubMed]
[68] Huang, J.-C., Huang, Y.-C., Lu, C., Chuang, Y., Chien, H., Lin, C., et al. (2024) Exploring the Relationship between Visceral Fat and Coronary Artery Calcification Risk Using Metabolic Score for Visceral Fat (Mets-VF). Life, 14, Article 1399. [Google Scholar] [CrossRef] [PubMed]
[69] Kuang, M.B., Qiu, J.J., Li, D.D., Hu, C., Zhang, S.H., Sheng, G.T., et al. (2023) The Newly Proposed Metabolic Score for Visceral Fat Is a Reliable Tool for Identifying Non-Alcoholic Fatty Liver Disease, Requiring Attention to Age-Specific Effects in Both Sexes. Frontiers in Endocrinology, 14, Article 1281524. [Google Scholar] [CrossRef] [PubMed]
[70] Qian, J.Y., Huang, G.Q. and Mao, Y.S. (2024) Association between Metabolic Score of Visceral Fat and Carotid Atherosclerosis in Chinese Health Screening Population: A Cross-Sectional Study. BMC Public Health, 24, Article No. 1723. [Google Scholar] [CrossRef] [PubMed]
[71] Feng, Y.F., Yang, X.J., Li, Y., Wu, Y.Y., Han, M.H., Qie, R.R., et al. (2022) Metabolic Score for Visceral Fat: A Reliable Indicator of Visceral Obesity for Predicting Risk for Hypertension. Nutrition, 93, Article 111443. [Google Scholar] [CrossRef] [PubMed]
[72] Kapoor, N., Jiwanmall, S.A., Nandyal, M.B., Kattula, D., Paravathareddy, S., Paul, T.V., et al. (2020) Metabolic Score for Visceral Fat (METS-VF) Estimation—A Novel Cost-Effective Obesity Indicator for Visceral Adipose Tissue Estimation. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 3261-3267. [Google Scholar] [CrossRef] [PubMed]
[73] Torun, C., Ankaralı, H., Caştur, L., Uzunlulu, M., Erbakan, A.N., Akbaş, M.M., et al. (2023) Is Metabolic Score for Visceral Fat (METS-VF) a Better Index than Other Adiposity Indices for the Prediction of Visceral Adiposity. Diabetes, Metabolic Syndrome and Obesity, 16, 2605-2615. [Google Scholar] [CrossRef] [PubMed]
[74] Wei, J., Liu, X., Xue, H., Wang, Y. and Shi, Z. (2019) Comparisons of Visceral Adiposity Index, Body Shape Index, Body Mass Index and Waist Circumference and Their Associations with Diabetes Mellitus in Adults. Nutrients, 11, Article 1580. [Google Scholar] [CrossRef] [PubMed]
[75] Deng, R.X., Chen, W.J., Zhang, Z.P., Zhang, J.Z., Wang, Y., Sun, B.C., et al. (2024) Association between Visceral Obesity Index and Diabetes: A Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 109, 2692-2707. [Google Scholar] [CrossRef] [PubMed]
[76] Wu, Z.Y., Yu, S.Q., Kang, X.P., Liu, Y., Xu, Z.K., Li, Z.W., et al. (2022) Association of Visceral Adiposity Index with Incident Nephropathy and Retinopathy: A Cohort Study in the Diabetic Population. Cardiovascular Diabetology, 21, Article No. 32. [Google Scholar] [CrossRef] [PubMed]
[77] Chen, J.H., Li, Y.T., Niu, Z.M., He, Z.P., Xie, Y.J., Hernandez, J., et al. (2024) Association of Visceral Obesity Indices with Incident Diabetic Retinopathy in Patients with Diabetes: Prospective Cohort Study. JMIR Public Health and Surveillance, 10, e48120. [Google Scholar] [CrossRef] [PubMed]
[78] Li, C.Y., Wang, G., Zhang, J.L., Jiang, W.M., Wei, S.W., Wang, W.N., et al. (2024) Association between Visceral Adiposity Index and Incidence of Diabetic Kidney Disease in Adults with Diabetes in the United States. Scientific Reports, 14, Article No. 17957. [Google Scholar] [CrossRef] [PubMed]
[79] Wei, B., Zhou, L., Shu, B.-L., Huang, Q.-Y., Chai, H., Yuan, H.-Y., et al. (2024) Association of Diabetic Retinopathy with Plasma Atherosclerotic Index, Visceral Obesity Index, and Lipid Accumulation Products: NHANES 2005-2008. Lipids in Health and Disease, 23, Article No. 331. [Google Scholar] [CrossRef] [PubMed]
[80] Randrianarisoa, E., Lehn-Stefan, A., Hieronimus, A., Rietig, R., Fritsche, A., Machann, J., et al. (2019) Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus. Journal of Atherosclerosis and Thrombosis, 26, 821-834. [Google Scholar] [CrossRef] [PubMed]
[81] Wung, C., Lee, M., Wu, P., Huang, J. and Chen, S. (2021) Obesity-Related Indices Are Associated with Peripheral Artery Occlusive Disease in Patients with Type 2 Diabetes Mellitus. Journal of Personalized Medicine, 11, Article 533. [Google Scholar] [CrossRef] [PubMed]
[82] Sun, Z., Wang, K., Yun, C., Bai, F., Yuan, X., Lee, Y., et al. (2023) Correlation between the Variability of Different Obesity Indices and Diabetic Kidney Disease. Diabetes, Metabolic Syndrome and Obesity, 16, 2791-2802. [Google Scholar] [CrossRef] [PubMed]
[83] Camhi, S.M., Bray, G.A., Bouchard, C., Greenway, F.L., Johnson, W.D., Newton, R.L., et al. (2011) The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences. Obesity, 19, 402-408. [Google Scholar] [CrossRef] [PubMed]
[84] Nazare, J., Smith, J.D., Borel, A., Haffner, S.M., Balkau, B., Ross, R., et al. (2012) Ethnic Influences on the Relations between Abdominal Subcutaneous and Visceral Adiposity, Liver Fat, and Cardiometabolic Risk Profile: The International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship with Cardiometabolic Risk/Intra-Abdominal Adiposity. The American Journal of Clinical Nutrition, 96, 714-726. [Google Scholar] [CrossRef] [PubMed]
[85] Ravani, J.P.R., Sbaffi, B.C., Monteiro, A.C., Carrocino, K.M.C., Doimo, L.A. and Ferreira, F.G. (2022) The Visceral Adiposity Index Is a Better Predictor of Excess Visceral Fat in Military Pilots: A Cross-Sectional Observational Study. Military Medicine, 188, e2003-e2009. [Google Scholar] [CrossRef] [PubMed]